HUT47847A - Process for producing new pharmaceutical suitable for treating hypertension and stagnant cardiac failure - Google Patents

Process for producing new pharmaceutical suitable for treating hypertension and stagnant cardiac failure

Info

Publication number
HUT47847A
HUT47847A HU874712A HU471287A HUT47847A HU T47847 A HUT47847 A HU T47847A HU 874712 A HU874712 A HU 874712A HU 471287 A HU471287 A HU 471287A HU T47847 A HUT47847 A HU T47847A
Authority
HU
Hungary
Prior art keywords
stagnant
treating hypertension
cardiac failure
producing new
new pharmaceutical
Prior art date
Application number
HU874712A
Other languages
Hungarian (hu)
Other versions
HU199681B (en
Inventor
Helene Siegl
Robert P Hof
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUT47847A publication Critical patent/HUT47847A/en
Publication of HU199681B publication Critical patent/HU199681B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU874712A 1986-11-03 1987-10-20 Process for producing new pharmaceutical composition against hypertension and atonic cardiac decomposition HU199681B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUT47847A true HUT47847A (en) 1989-04-28
HU199681B HU199681B (en) 1990-03-28

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
HU874712A HU199681B (en) 1986-11-03 1987-10-20 Process for producing new pharmaceutical composition against hypertension and atonic cardiac decomposition

Country Status (25)

Country Link
KR (1) KR960005145B1 (en)
AT (1) AT397343B (en)
AU (1) AU615883B2 (en)
BE (1) BE1002063A4 (en)
CA (1) CA1314222C (en)
CH (1) CH677189A5 (en)
DE (1) DE3736505A1 (en)
DK (1) DK574087A (en)
ES (1) ES2010524A6 (en)
FI (1) FI874823A (en)
FR (1) FR2605885B1 (en)
GR (1) GR871680B (en)
HK (1) HK138893A (en)
HU (1) HU199681B (en)
IE (1) IE60496B1 (en)
IL (1) IL84343A (en)
IT (1) IT1212037B (en)
LU (1) LU87034A1 (en)
MY (1) MY102124A (en)
NL (1) NL8702502A (en)
NO (1) NO874539L (en)
NZ (1) NZ222401A (en)
PH (1) PH23249A (en)
PT (1) PT86062B (en)
SE (1) SE8704272L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (en) * 1988-05-28 1989-12-07 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH COLD CHANNEL MODULATORS AND THEIR USE IN MEDICINAL PRODUCTS
FR2733911B1 (en) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd PHARMACEUTICAL COMPOSITION FOR RENAL OR CARDIOVASCULAR DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (en) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen COMBINATION OF DIHYDROPYRIDINE WITH ACE INHIBITORS AND THEIR USE IN MEDICINAL PRODUCTS
DE3633496A1 (en) * 1986-10-02 1988-04-14 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH CALCIUMANTAGONISTS AND THEIR USE IN MEDICINAL PRODUCTS
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
GR871680B (en) 1988-05-02
FR2605885A1 (en) 1988-05-06
NO874539L (en) 1988-05-04
FI874823A (en) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (en) 1990-11-07
IL84343A0 (en) 1990-02-09
ES2010524A6 (en) 1989-11-16
IL84343A (en) 1993-07-08
KR960005145B1 (en) 1996-04-22
CA1314222C (en) 1993-03-09
CH677189A5 (en) 1991-04-30
DK574087A (en) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (en) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
SE8704272D0 (en) 1987-11-02
MY102124A (en) 1992-03-31
PT86062A (en) 1987-12-01
AU615883B2 (en) 1991-10-17
LU87034A1 (en) 1988-05-03
IE60496B1 (en) 1994-07-27
IT1212037B (en) 1989-11-08
SE8704272L (en) 1988-05-04
FR2605885B1 (en) 1993-09-10
NO874539D0 (en) 1987-11-02
DK574087D0 (en) 1987-11-02
FI874823A0 (en) 1987-11-02
BE1002063A4 (en) 1990-06-12
IT8748553A0 (en) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (en) 1988-05-05
NL8702502A (en) 1988-06-01
AT397343B (en) 1994-03-25
KR880006197A (en) 1988-07-22

Similar Documents

Publication Publication Date Title
US5389677B1 (en) Method of treating wrinkles using glycalic acid
GB2157178B (en) Apparatus for treating disorders of cardiac rhythm
DE3574228D1 (en) Rate scanning demand pacemaker and method for treatment of tachycardia
HUT45473A (en) Process for producing new pyrocatechine derivatives and pharmaceutics comprising such compounds
HUT64699A (en) Process for production of preparations for the treatment of disorders and disearses
HUT45487A (en) Process for producing spiro-substituted-glutaramide derivatives and pharmaceutics comprising such compounds
HUT46541A (en) Process for production of new cimetidine medical preparatives
HUT47956A (en) Process for producing 2,3-disubstituted izoxazolidines and pharmaceuticals comprising same
PT80658B (en) Process for the preparation of amino-acids and therapeutic method thereof
PT85257A (en) Process for the preparation of new 4-puridone derivatives and their physiologically assimilable salts and esters
AU2387988A (en) Method of treating skin disorders
HUT47272A (en) Process for production of derivatives of pirid, pirasole and izotriasole-triazin
PH22718A (en) Method for treating congestive heart failure
EP0236675A3 (en) Process for producing modified pitch and its use
HUT47847A (en) Process for producing new pharmaceutical suitable for treating hypertension and stagnant cardiac failure
HUT47849A (en) Process for producing new pharmaceutical with analgetic and hypertonicity-relaxing effect
EP0149519A3 (en) Method of treating heart disease
GR861655B (en) Preparation process for a medicine used for the psoriasis treatment and application therefor
HUT47258A (en) Process for production of tetrasole-derivatives decreasing the pathalogically high colestherin-level of blood and intermediers applicable for their production
HUT49858A (en) Process for producing 5-arilidene and 5-alkilidene hydantoins
GB2186570B (en) 9,10-dihydro-phenanthrene derivatives and process for their preparation
HUT45043A (en) Process for producing new ketolactones and their salts
HUT44495A (en) Process for production of 4-hydroxi-piperidine and its alkyl-derivatives
ZA877785B (en) Iminooxazolidines,process of preparation and method of use
GB8618949D0 (en) Method of treatment

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HPC4 Succession in title of patentee

Owner name: NOVARTIS AG, CH

HMM4 Cancellation of final prot. due to non-payment of fee